{"entity":{"type":"insider","cik":"0001413525","url":"/insider/0001413525","json_url":"/insider/0001413525.json","name":"Tarnok Michael P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2007-11-20","last":"2015-05-06","span_basis":"filed_date"},"name_variants":[{"name":"Tarnok Michael P.","source":"filing","n_filings":5,"first_seen":"2007-11-20","last_seen":"2015-05-06"}],"transactions":[{"id":8460153,"accession":"0001209191-15-039399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-039399","line_url":"/filing/0001209191-15-039399#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001413525","owner_name":"Tarnok Michael P.","owner_display_name":"Tarnok Michael P.","owner_url":"/insider/0001413525","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.73,"price_display":"9.73","price_state":"stated","total_value":97300.0,"total_display":"97,300.00","total_whole":"97,300","shares_owned_after":328600.0,"shares_owned_after_display":"328,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-06","filed_date":"2015-05-06","scope":"insider"},{"id":3075475,"accession":"0001144204-12-020647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-020647","line_url":"/filing/0001144204-12-020647#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001413525","owner_name":"Tarnok Michael P.","owner_display_name":"Tarnok Michael P.","owner_url":"/insider/0001413525","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":27125.0,"total_display":"27,125.00","total_whole":"27,125","shares_owned_after":278600.0,"shares_owned_after_display":"278,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-05","filed_date":"2012-04-09","scope":"insider"},{"id":8967066,"accession":"0001144204-11-045468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-045468","line_url":"/filing/0001144204-11-045468#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001413525","owner_name":"Tarnok Michael P.","owner_display_name":"Tarnok Michael P.","owner_url":"/insider/0001413525","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":46500.0,"total_display":"46,500.00","total_whole":"46,500","shares_owned_after":261100.0,"shares_owned_after_display":"261,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-10","filed_date":"2011-08-11","scope":"insider"},{"id":6051265,"accession":"0001144204-09-029539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-029539","line_url":"/filing/0001144204-09-029539#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001413525","owner_name":"Tarnok Michael P.","owner_display_name":"Tarnok Michael P.","owner_url":"/insider/0001413525","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":18400.0,"total_display":"18,400.00","total_whole":"18,400","shares_owned_after":191100.0,"shares_owned_after_display":"191,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-26","filed_date":"2009-05-27","scope":"insider"},{"id":8033482,"accession":"0001144204-07-063537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-07-063537","line_url":"/filing/0001144204-07-063537#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001413525","owner_name":"Tarnok Michael P.","owner_display_name":"Tarnok Michael P.","owner_url":"/insider/0001413525","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":9581.0,"total_display":"9,581.00","total_whole":"9,581","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2007-11-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001114220","name":"KERYX BIOPHARMACEUTICALS INC","url":"/issuer/0001114220","role":"Director","n_filings":5,"first_seen":"2007-11-20","last_seen":"2015-05-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001413525","retrieved_at":"2026-08-26T12:12:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}